Business Context and Reporting Period
This Form 6-K filing by Smith & Nephew plc, dated August 13, 2025, serves as a notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs). The report details the vesting of share awards under the Global Share Plan 2020.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It is strictly a regulatory disclosure regarding equity compensation events.
Material Changes
The filing reports a specific transaction involving the partial vesting of 2023 Conditional Awards granted on August 11, 2023. The awards vest in equal tranches over three years. On August 12, 2025, shares were vested and subsequently sold to cover taxation obligations.
Management Commentary and Unusual Items
There is no management commentary, guidance, outlook, or discussion of risks and contingencies in this document. The only unusual item is the specific equity transaction detailed below:
- Individual: Rohit Kashyap (President, Advanced Wound Management and Global PDMR).
- Transaction Date: August 12, 2025.
- Instrument: Smith & Nephew plc ordinary shares of USD 0.20 each (ISIN: GB0009223206).
- Volume: 23,201 shares vested.
- Disposition: 5,670 shares were sold to cover tax liability; 17,531 shares were retained.
- Price: £13.571365 per share.
- Place of Transaction: London Stock Exchange (XLON).
Investor Verification Checklist
- Verify the total number of shares retained by Rohit Kashyap (17,531) against his total holdings in subsequent filings.
- Confirm the tax rate implied by the sale of 5,670 shares out of 23,201 vested shares.
- Check the company's annual report (Form 20-F) for the full terms of the Global Share Plan 2020 to understand future vesting schedules.
- Note that this filing contains no operational or financial performance updates for the period.